4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-002617
President sold 30,000 shares at an average $56.10 ($1,682,877)
- President acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
RUBINSTEIN JULIE · President
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-06 | Exercise or conversion : show line 1 in the form | +15,000 | $6.32 | $94,800 | 15,000 | D |
| 2021-01-06 | Sale : show line 2 in the form | −14,192 | $54.86 | $778,573 | 808 | D |
| 2021-01-06 | Sale : show line 3 in the form | −808 | $55.45 | $44,804 | 0 | D |
| 2021-01-07 | Exercise or conversion : show line 4 in the form | +15,000 | $6.32 | $94,800 | 15,000 | D |
| 2021-01-07 | Sale : show line 5 in the form | −15,000 | $57.30 | $859,500 | 0 | D |
| Open-market sales · 30,000 sh · avg $56.10 · $1,682,877 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-01-06 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −15,000 | 335,000 | D |
| 2021-01-07 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −15,000 | 320,000 | D |
Loading xslF345X03/doc4.xml…